Cargando…
Novel C6-substituted 1,3,4-oxadiazinones as potential anti-cancer agents
The insulin-like growth factor 1 receptor (IGF-1R) is a membrane receptor tyrosine kinase over-expressed in a number of tumors. However, combating resistance is one of the main challenges in the currently available IGF-1R inhibitor-based cancer therapies. Increased Src activation has been reported t...
Autores principales: | Alam, Md. Maqusood, Lee, Su-Chan, Jung, Yujin, Yun, Hye Jeong, Min, Hye-Young, Lee, Ho Jin, Pham, Phuong Chi, Moon, Jayoung, Kwon, Dah In, Lim, Bumhee, Suh, Young-Ger, Lee, Jeeyeon, Lee, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747355/ https://www.ncbi.nlm.nih.gov/pubmed/26515601 |
Ejemplares similares
-
Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
por: Lee, Ho Jin, et al.
Publicado: (2018) -
Correction: Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
por: Lee, Ho Jin, et al.
Publicado: (2023) -
Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor
por: Lee, Ho Jin, et al.
Publicado: (2021) -
Practical and Sustainable Synthesis of Optically Pure Levocabastine, a H(1) Receptor Antagonist
por: Kang, Sung Kwon, et al.
Publicado: (2017) -
A Peptoid-Based Fluorescent Sensor for Cyanide Detection
por: Lim, Bumhee, et al.
Publicado: (2016)